This post must end up being hereby proclaimed advert relating as a result with 18 U.S.C. resulting in adjustments in both extracellular quantity and blood circulation pressure. Growth of extracellular volume occurs in a variety of clinical disorders, including nephrotic syndrome. The role of ENaC activation in many of the clinical disorders associated with extracellular volume expansion remains to be defined. ENaC activity in the cells that collection the distal nephron depends on the number of channels in the apical membrane and on channel open probability (Po) (1). ENaC subunits undergo post-translational processing by specific proteases (2-9). Cleavage of the and subunits by proteases has a important role in activating ENaC, presumably by releasing inhibitory domains within the ectodomains of the and subunits (3,5,10,11). We have proposed that multiple proteolytic cleavage events lead to a stepwise activation of ENaC, reflected in a stepwise increase in channelPo(3,5,10,12). Channels that lack proteolytic processing have a lowPo(3,10,12,13). Channels that have been cleaved solely by furin, where an subunit inhibitory tract has been released, exhibit Ibutamoren (MK-677) an intermediatePo(3,10,12). Furin-processed channels likely represent the channels that are observed inXenopusoocytes at a single channel level. Channels that have released both and subunit inhibitory tracts exhibit a highPo, as we observed in oocytes co-expressing ENaC and prostasin (3,5). Both non-cleaved channels and furin-processed channels at the plasma membrane provide a reservoir of channels that can be activated by extracellular proteases Goserelin Acetate (3,14). One potential activator of ENaC is the serine protease plasmin. Although known for its involvement in fibrinolysis, plasmin has been implicated in other processes, including tumor pathogenesis, inflammation, and atherosclerosis (15). Plasmin cleaves after basic residues (Arg and Lys) much like trypsin, a known activator of ENaC (16,17). Plasminogen, the inactive precursor to plasmin, is usually recovered at higher concentrations in the urine of individuals with nephrotic syndrome compared with healthy individuals (18,19). Urokinase, an enzyme that converts plasminogen to plasmin, is usually released by cells lining both the proximal and distal nephron (20-22). As active plasmin may be present in the distal nephron in the setting of nephrotic syndrome, it is important to determine whether plasmin can cleave and activate ENaC. We have now shown that extracellular plasmin activates ENaC expressed inXenopusoocytes. Channel activation by plasmin is dependent on cleavage of the subunit at a site that is in close proximity to defined sites for prostasin- and elastase-dependent cleavage of the subunit (5,7,8). == EXPERIMENTAL PROCEDURES == DNA Constructs, Site-directed Mutagenesis, and cRNAsWild-type and mutant mouse ENaC constructs, including the prostasin-dependent cleavage site mutant (RKRK186to QQQQ186), contained amino-terminal HA and carboxyl-terminal V5 epitope tags as explained previously (5,23). The K194A point mutation was generated using a PCR-based approach (24). T3 or T7 mMessage mMachine (Ambion, Austin, TX) was used to synthesize cRNAs for ENaC, ENaC, and ENaC (wild-type and mutant). Functional Expression in Xenopus OocytesENaC subunits were expressed in Stage V-VIXenopus laevisoocytes pre-treated with 1.5 mg/ml type IV collagenase (25). ENaC cRNAs were injected at a concentration of 2 ng/subunit/oocyte. Electrophysiological measurements were performed at 24-32 h post injection using two-electrode voltage clamp (TEV) as explained previously (25). The bath answer was 100 mmsodium gluconate, 1.54 mmCaCl2, 5 mmBaCl2, 10 mmHEPES, 10 mmtetraethylammonium chloride, pH 7.4. Selected oocytes were bathed in TEV buffer with bovine plasmin (10 g/ml; Innovative Research, Inc., Novi, MI) for defined time periods. The amiloride-insensitive component of the whole cell current was determined by perfusion with bath answer supplemented with amiloride (100 m). Currents measured at -60 mV were recorded at base line and at varying occasions of exposure to plasmin. Detection of the Surface Pool of ENaC in OocytesTwenty-four h post-injection, oocytes (15-40 per group) were placed in Ibutamoren (MK-677) altered Barth’s saline (88 mmNaCl, 1 mmKCl, 2.4 mmNaHCO3, 15 mmHEPES, 0.3 mmCa(NO3)2, 0.41 Ibutamoren (MK-677) mmCaCl2, 0.82 mmMgSO4, pH 7.4) supplemented with 10 mamiloride. Oocytes expressing ENaC made up of wild-type or mutant subunits were incubated with or without plasmin (10 g/ml) for 4 min at room temperature and then placed immediately on ice and washed with ice-cold altered Barth’s saline. Oocyte surface proteins were biotinylated, and surface V5-tagged ENaC was recovered with streptavidin beads (Pierce) for immunoblotting with anti-V5 antibodies as explained previously (5,7). Detection of the Surface.